Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266

Watchlist Manager
Suzhou Zelgen Biopharmaceuticals Co Ltd Logo
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Watchlist
Price: 67.99 CNY -0.89% Market Closed
Market Cap: 18B CNY
Have any thoughts about
Suzhou Zelgen Biopharmaceuticals Co Ltd?
Write Note

Relative Value

The Relative Value of one Suzhou Zelgen Biopharmaceuticals Co Ltd stock under the Base Case scenario is 70.56 CNY. Compared to the current market price of 67.99 CNY, Suzhou Zelgen Biopharmaceuticals Co Ltd is Undervalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
70.56 CNY
Undervaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
25
Median 3Y
35
Median 5Y
35.5
Industry
8.1
Forward
29.4
vs History
vs Industry
Median 3Y
-37.9
Median 5Y
-41.3
Industry
23
Forward
-120.2
vs History
1
vs Industry
Median 3Y
-31.5
Median 5Y
-37.7
Industry
23.4
vs History
16
vs Industry
2
Median 3Y
-18.7
Median 5Y
-37.5
Industry
27.3
vs History
41
vs Industry
9
Median 3Y
9.2
Median 5Y
9.7
Industry
2.6
vs History
33
vs Industry
23
Median 3Y
32.4
Median 5Y
32.7
Industry
8.1
Forward
27
vs History
33
vs Industry
17
Median 3Y
34.8
Median 5Y
35.2
Industry
9.6
vs History
vs Industry
Median 3Y
-29.5
Median 5Y
-32.3
Industry
4.3
Forward
-267.7
vs History
vs Industry
Median 3Y
-29.5
Median 5Y
-32.3
Industry
3.8
Forward
-71
vs History
1
vs Industry
Median 3Y
-28.8
Median 5Y
-33.8
Industry
6
vs History
vs Industry
Median 3Y
-27.6
Median 5Y
-30.9
Industry
3.8
vs History
41
vs Industry
11
Median 3Y
22
Median 5Y
24.8
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Suzhou Zelgen Biopharmaceuticals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
18B CNY 44.2 -77.9 -55.6 -55.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Average P/E: 211.8
Negative Multiple: -77.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Average EV/EBITDA: 17.9
Negative Multiple: -55.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Average EV/EBIT: 23.2
Negative Multiple: -55.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top